Late cardiopulmonary morbidity in patients with Hodgkin lymphoma: a retrospective nationwide registry study
Late cardiopulmonary morbidity in patients with Hodgkin lymphoma: a retrospective nationwide registry study.
This study reports the incidence of late‑onset cardiopulmonary complications in long‑term survivors of Hodgkin lymphoma treated with contemporary modalities, underscoring the need for long‑term surveillance, early detection and preventive interventions to improve quality‑of‑life and reduce morbidity in this cohort.
Evidence level: Számítógépes vagy elméleti. Modellből vagy adatbányászatból származó jel.
Related signals
- Advanced Classical Hodgkin Lymphoma Management in East and Southeast Asia: Real-World Challenges and Aspirations of the Asian Lymphoma Study Group.
- Overcoming PD‑1 Resistance in Relapsed/Refractory Hodgkin Lymphoma
- Progress in the Treatment of Advanced-Stage Classical Hodgkin Lymphoma in the PET-Adapted Era
- Combination of Acimtamig and AlloNK Effective in R/R Classical Hodgkin Lymphoma
- Working towards harmonization of clinical trial reporting in Hodgkin lymphoma